What does plant-based vaccine technology offer to the fight against COVID-19?

S Rosales-Mendoza, VA Márquez-Escobar… - Vaccines, 2020 - mdpi.com
The emergence of new pathogenic viral strains is a constant threat to global health, with the
new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS …

[HTML][HTML] Revisiting influenza A virus life cycle from a perspective of genome balance

R Du, Q Cui, Z Chen, X Zhao, X Lin, L Rong - Virologica Sinica, 2023 - Elsevier
Influenza A virus (IAV) genome comprises eight negative-sense RNA segments, of which the
replication is well orchestrated and the delicate balance of multiple segments are …

Combating human viral diseases: will plant-based vaccines be the answer?

S Venkataraman, K Hefferon, A Makhzoum… - Vaccines, 2021 - mdpi.com
Molecular pharming or the technology of application of plants and plant cell culture to
manufacture high-value recombinant proteins has progressed a long way over the last three …

A comprehensive overview on the production of vaccines in plant-based expression systems and the scope of plant biotechnology to combat against SARS-CoV-2 …

M Kumar, N Kumari, N Thakur, SK Bhatia, GD Saratale… - Plants, 2021 - mdpi.com
Many pathogenic viral pandemics have caused threats to global health; the COVID-19
pandemic is the latest. Its transmission is growing exponentially all around the globe, putting …

Expanding the tolerance of segmented Influenza A Virus genome using a balance compensation strategy

X Zhao, X Lin, P Li, Z Chen, C Zhang… - PLoS …, 2022 - journals.plos.org
Reporter viruses provide powerful tools for both basic and applied virology studies,
however, the creation and exploitation of reporter influenza A viruses (IAVs) have been …

Development of a T cell-based COVID-19 vaccine using a live attenuated influenza vaccine viral vector

I Isakova-Sivak, E Stepanova, V Matyushenko… - Vaccines, 2022 - mdpi.com
The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all
countries in the world. SARS-CoV-2 continues to circulate and antigenically evolve …

Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin

BR Park, KH Kim, T Kotomina, MC Kim, YM Kwon… - Scientific Reports, 2021 - nature.com
Hemagglutinin (HA)-based current vaccines provide suboptimum cross protection. Influenza
A virus contains an ion channel protein M2 conserved extracellular domain (M2e), a target …

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

A Vieira Antão, F Oltmanns, A Schmidt… - Frontiers in …, 2024 - frontiersin.org
Influenza A Virus (IAV) and Respiratory Syncytial Virus (RSV) are both responsible for
millions of severe respiratory tract infections every year worldwide. Effective vaccines able to …

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung …

V Matyushenko, T Kotomina, I Kudryavtsev… - Antiviral Research, 2020 - Elsevier
Respiratory syncytial virus (RSV) can cause recurrent infection in people because it does
not stimulate a long-lived immunological memory. There is an urgent need to develop a safe …

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice

A Pulkina, K Vasilyev, A Muzhikyan… - International Journal of …, 2023 - mdpi.com
Intranasal vaccination using influenza vectors is a promising approach to developing
vaccines against respiratory pathogens due to the activation of the mucosa-associated …